SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001013762-14-000425
Filing Date
2014-04-17
Accepted
2014-04-17 16:05:30
Documents
10

Document Format Files

Seq Description Document Type Size
1 DELMAR PHARMACEUTICALS, INC. FORM POS AM formposam.htm POS AM 2476748
2 GRAPHIC graph.jpg GRAPHIC 33038
3 GRAPHIC graph2.jpg GRAPHIC 17652
4 EXHIBIT 23.1 ex231.htm EX-23.1 4864
  Complete submission text file 0001013762-14-000425.txt   9826744

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT dmpi-20131231.xml EX-101.INS 1211923
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dmpi-20131231.xsd EX-101.SCH 94553
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmpi-20131231_cal.xml EX-101.CAL 32889
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmpi-20131231_def.xml EX-101.DEF 327244
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE dmpi-20131231_lab.xml EX-101.LAB 602975
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmpi-20131231_pre.xml EX-101.PRE 470846
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-189337 | Film No.: 14770154
SIC: 2834 Pharmaceutical Preparations